Segment Information

9 Months Ended

Oct. 01, 2021

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION

The Company operates and reports its results in three separate business segments consisting of the Life Sciences, Diagnostics, and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.

Segment results are shown below ($ in millions):

	Three-Month Period Ended				Nine-Month Period Ended
	October 1, 2021		October 2, 2020		October 1, 2021		October 2, 2020
Sales:
Life Sciences	$	3,632	$	2,923	$	10,912	$	7,215
Diagnostics	2,449		1,889		6,963		5,176
Environmental & Applied Solutions	1,148		1,072		3,430		3,133
Total	$	7,229	$	5,884	$	21,305	$	15,524
Operating profit:
Life Sciences	$	975	$	505	$	3,270	$	1,243
Diagnostics	145		408		1,420		952
Environmental & Applied Solutions	256		245		821		707
Other	(67)		(70)		(200)		(272)
Total	$	1,309	$	1,088	$	5,311	$	2,630